Andrew J Pollard Selected Research

Bacteremia

1/2017	Identification of Novel Serodiagnostic Signatures of Typhoid Fever Using a Salmonella Proteome Array.
1/2017	Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model.
1/2016	Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever.
5/2014	An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew J Pollard Research Topics

Disease

98	Infections 04/2024 - 06/2002
65	Typhoid Fever (Typhoid) 04/2024 - 06/2007
36	COVID-19 05/2024 - 01/2020
29	Meningococcal Infections 01/2023 - 02/2003
22	Diphtheria 07/2023 - 04/2005
19	Fever (Fevers) 11/2023 - 09/2010
17	Whooping Cough (Pertussis) 07/2023 - 04/2005
16	Bacterial Infections (Bacterial Infection) 11/2023 - 12/2005
15	Tetanus 07/2023 - 04/2005
13	Pneumococcal Infections 02/2024 - 01/2007
12	Poliomyelitis (Polio) 01/2022 - 04/2005
11	Communicable Diseases (Infectious Diseases) 01/2022 - 05/2011
10	Measles 12/2022 - 06/2013
9	Meningitis 01/2024 - 03/2010
9	Human Influenza (Influenza) 01/2021 - 03/2012
8	Virus Diseases (Viral Diseases) 11/2023 - 08/2016
8	Mumps 12/2022 - 06/2013
8	Pain (Aches) 11/2022 - 01/2008
7	Hepatitis B 01/2021 - 03/2008
6	Respiratory Syncytial Virus Infections 01/2024 - 01/2019
6	Rubella (German Measles) 01/2022 - 06/2015
6	Vaccinia 10/2021 - 04/2016
5	Breakthrough Infections 04/2024 - 01/2022
5	Encephalitis (Encephalitis, Rasmussen) 11/2023 - 01/2017
5	Pharyngitis (Sore Throat) 01/2021 - 09/2010
5	Bacterial Meningitis 12/2018 - 01/2009
4	Pneumonia (Pneumonitis) 02/2024 - 01/2009
4	Japanese Encephalitis 04/2023 - 10/2017
4	Headache (Headaches) 12/2021 - 08/2006
4	Sepsis (Septicemia) 01/2019 - 11/2010
4	Disease Susceptibility (Diathesis) 01/2018 - 10/2004
4	Bacteremia 01/2017 - 05/2014
3	Viral Meningitis 01/2024 - 03/2015
3	Salmonella Infections (Salmonellosis) 01/2020 - 03/2013
3	Aphthous Stomatitis (Aphthous Ulcer) 12/2019 - 09/2010
3	Lymphadenitis (Adenitis) 12/2019 - 09/2010
3	Inflammation (Inflammations) 09/2015 - 05/2010
2	Pneumococcal Pneumonia 02/2024 - 01/2019
2	Autoimmune Diseases of the Nervous System 11/2023 - 01/2023
2	Q Fever (Fever, Q) 01/2023 - 01/2022
2	Vaccine-Preventable Diseases 01/2022 - 01/2020
2	Paratyphoid Fever 12/2021 - 01/2017
2	Asymptomatic Infections 11/2021 - 01/2018
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Cough 10/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

177	VaccinesIBA 05/2024 - 06/2002
72	Conjugate VaccinesIBA 04/2024 - 04/2005
31	AntigensIBA 04/2024 - 01/2006
29	Proteins (Proteins, Gene)FDA Link 05/2024 - 07/2004
27	Polysaccharides (Glycans)IBA 02/2024 - 02/2003
20	ChAdOx1 nCoV-19IBA 04/2024 - 01/2020
19	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 03/2010
18	AntibodiesIBA 01/2023 - 04/2005
15	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2023 - 04/2005
13	Immunoglobulin G (IgG)IBA 02/2024 - 12/2010
11	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2010
10	COVID-19 VaccinesIBA 04/2024 - 01/2020
10	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 12/2021 - 06/2015
7	TCVSIBA 12/2023 - 10/2018
6	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 12/2015
6	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018 - 03/2012
5	MenACWYIBA 12/2022 - 01/2008
5	CytokinesIBA 01/2022 - 05/2004
5	FluoroquinolonesIBA 01/2022 - 01/2018
5	GlycoconjugatesIBA 12/2021 - 09/2006
5	Glycoproteins (Glycoprotein)IBA 01/2021 - 04/2016
5	Capsules (Microcapsules)IBA 08/2012 - 02/2003
4	RNA (Ribonucleic Acid)IBA 04/2024 - 08/2016
4	LipopolysaccharidesIBA 01/2023 - 05/2014
4	Meningococcal Vaccines (Meningococcal Vaccine)IBA 11/2022 - 03/2016
4	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2020 - 11/2016
3	AutoantibodiesIBA 11/2023 - 05/2010
3	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2023 - 01/2022
3	Combined VaccinesIBA 10/2023 - 02/2015
3	Attenuated VaccinesIBA 01/2023 - 01/2017
3	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2017
3	Carrier Proteins (Binding Protein)IBA 10/2021 - 01/2016
3	Nucleic AcidsIBA 10/2021 - 01/2021
3	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 01/2021 - 04/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2004
3	NucleoproteinsIBA 01/2021 - 06/2012
3	C-Reactive ProteinIBA 01/2021 - 03/2015
3	Neutralizing AntibodiesIBA 01/2021 - 04/2016
3	Immunoglobulin A (IgA)IBA 01/2019 - 01/2015
3	EnzymesIBA 05/2017 - 06/2012
3	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 05/2014 - 03/2009
3	Phosphates (Orthophosphate)IBA 01/2014 - 04/2005
2	S-268019-b COVID-19 vaccineIBA 05/2024 - 01/2024
2	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2017
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2023 - 10/2017
2	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023 - 01/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2022
2	EpitopesIBA 01/2022 - 01/2018
2	4CMenB vaccineIBA 01/2022 - 04/2015

Therapy/Procedure

9	Therapeutics 09/2023 - 05/2004
4	Length of Stay 01/2024 - 03/2015
4	Critical Care (Surgical Intensive Care) 12/2022 - 08/2016
3	Tonsillectomy 12/2019 - 09/2010
2	Intramuscular Injections 01/2024 - 01/2020
2	Injections 01/2023 - 01/2021